LGenia Logo

Fortville, Indiana

Member since 2018

Lgenia team, photo by Steven Berthel (09/2019)


Phillip Hipskind PhD, CEO


  • Greg Durst
  • Karen Lobb
  • Dave Mendel
  • Miles Siegel
  • Kenn Henry


Lgenia was founded in 2017 to exclusively focus on new medicines discovery for neglected diseases that disproportionately affect those living in poverty.  As a full member of the Bill and Melinda Gates Foundation’s TB Drug Accelerator and the Malaria Drug Accelerator, Lgenia is currently attacking the daunting challenge of early stage lead generation for these important global health concerns.

Role and Expertise

Lgenia has vast experience in lead generation science. We have contributed multiple leads and candidates in many therapeutic areas. Our capabilities include the following:

  • Medicinal Chemistry
  • Lead Generation and Optimization
  • ADME Problem Solving and Optimization
  • Toxicology Problem Solving and Optimization
  • Drug Development Problem Solving
  • Project Management
  • Organic Chemistry Synthesis